<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337050</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Retinal and Corneal OCT Results of Patients Hospitalized and Treated in the Acute Phase of COVID-19.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5564</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13185564</ELocationID><Abstract><AbstractText><b>Objective:</b> This study aimed to assess changes in the morphology of the retina and cornea in patients treated and hospitalized during the acute active phase of SARS-CoV-2 infection. <b>Methods:</b> A total of 24 patients with symptomatic early COVID-19 disease and 38 healthy participants from a control group were enrolled in our study. Among them, 20 received oxygen therapy at flow rates ranging from 1-10 L, while four received high-flow intranasal oxygen therapy (HFNOT). Some patients were treated with other types of therapy, such as Remdesivir, COVID-19 convalescent plasma therapy, or Tocilizumab. In the study, we focused on the analysis of optical coherence tomography (OCT) images of the cornea and retina including corneal thickness, central retinal thickness, retinal nerve fiber layer (RNFL), and optic disc parameters. The measurements were acquired using Spectral-domain OCT REVO FC 130. <b>Results:</b> The analysis did not show significant changes between the examined ophthalmological parameters before and after therapy. Furthermore, there were no detected significant differences between the tested parameters of the retina and cornea in COVID-19-positive patients compared to the control group. <b>Conclusions:</b> No ophthalmological manifestations of COVID-19 disease were observed during the study. Taking into account the results of other publications, the lack of an unambiguous position on this topic requires further research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wylęgała</LastName><ForeName>Edward</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6707-5790</Identifier><AffiliationInfo><Affiliation>Chair and Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-760 Katowice, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Railway Hospital, 40-760 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prus-Ludwig</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Railway Hospital, 40-760 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mocek</LastName><ForeName>Patrycja</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Ophthalmology Department, I School of Medicine, Katowice, Medical University of Silesia, 40-514 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomczyk</LastName><ForeName>Tomasz</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Ophthalmology Department, I School of Medicine, Katowice, Medical University of Silesia, 40-514 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dugiełło</LastName><ForeName>Bogdan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Chair and Clinical Department of Ophthalmology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-760 Katowice, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Railway Hospital, 40-760 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madej</LastName><ForeName>Andrzej</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, WSB University, 41-300 Dąbrowa Górnicza, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orzechowska-Wylęgała</LastName><ForeName>Bogusława</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5950-2425</Identifier><AffiliationInfo><Affiliation>Department of Pediatric Otolaryngology, Head and Neck Surgery, Department of Pediatric Surgery, Medical University of Silesia, 40-760 Katowice, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wylęgała</LastName><ForeName>Adam</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7295-4936</Identifier><AffiliationInfo><Affiliation>Health Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences, Medical University of Silesia, 40-752 Katowice, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 convalescent plasma therapy</Keyword><Keyword MajorTopicYN="N">cornea</Keyword><Keyword MajorTopicYN="N">optical coherence tomography (OCT)</Keyword><Keyword MajorTopicYN="N">oxygen therapy</Keyword><Keyword MajorTopicYN="N">remdesivir</Keyword><Keyword MajorTopicYN="N">retina</Keyword><Keyword MajorTopicYN="N">tocilizumab</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337050</ArticleId><ArticleId IdType="pmc">PMC11432357</ArticleId><ArticleId IdType="doi">10.3390/jcm13185564</ArticleId><ArticleId IdType="pii">jcm13185564</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organisation  COVID-19 Epidemiological Update Edition 165, 15 March 2024.  [(accessed on 15 April 2024)].  Available online:  https://iris.who.int/handle/10665/376322.</Citation></Reference><Reference><Citation>Torabizadeh C., Iloonkashkooli R., Haghshenas H., Fararouei M. Prevalence of Cardiovascular Complications in Coronavirus Disease 2019 adult Patients: A Systematic Review and Meta-Analysis. Iran. J. Med. Sci. 2023;48:243–267. doi: 10.30476/IJMS.2022.93701.2504.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/IJMS.2022.93701.2504</ArticleId><ArticleId IdType="pmc">PMC10542931</ArticleId><ArticleId IdType="pubmed">37791325</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017–1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung E.H., Fan J., Flynn H.W., Albini T.A. Ocular and Systemic Complications of COVID-19: Impact on Patients and Healthcare. Clin. Ophthalmol. 2022;16:1–13. doi: 10.2147/OPTH.S336963.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OPTH.S336963</ArticleId><ArticleId IdType="pmc">PMC8742614</ArticleId><ArticleId IdType="pubmed">35018092</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari M., Dourandeesh M. Update on overview of ocular manifestations of COVID-19. Front. Med. 2022;9:877023. doi: 10.3389/fmed.2022.877023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.877023</ArticleId><ArticleId IdType="pmc">PMC9513125</ArticleId><ArticleId IdType="pubmed">36177323</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J., Chen R., Zhao H., Zhu Y. COVID-19 and ocular complications: A review of ocular manifestations, diagnostic tools, and prevention strategies. Adv. Ophthalmol. Pract. Res. 2023;3:33–38. doi: 10.1016/j.aopr.2022.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aopr.2022.11.001</ArticleId><ArticleId IdType="pmc">PMC9714126</ArticleId><ArticleId IdType="pubmed">36471811</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi A., Torre A., Parrulli S., Zicarelli F., Schiuma M., Colombo V., Giacomelli A., Cigada M., Milazzo L., Ridolfo A., et al. Retinal findings in patients with COVID-19: Results from the SERPICO-19 study. EClinicalMedicine. 2020;27:100550. doi: 10.1016/j.eclinm.2020.100550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100550</ArticleId><ArticleId IdType="pmc">PMC7502280</ArticleId><ArticleId IdType="pubmed">32984785</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgos-Blasco B., Güemes-Villahoz N., Morales-Fernandez L., Callejas-Caballero I., Perez-Garcia P., Donate-Lopez J., Ramos-Amador J.T., Garcia-Feijoo J. Retinal nerve fibre layer and ganglion cell layer changes in children who recovered from COVID-19: A cohort study. Arch. Dis. Child. 2022;107:175–179. doi: 10.1136/archdischild-2021-321803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-321803</ArticleId><ArticleId IdType="pubmed">34340983</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolokoltsev O., Gómez-Arista I., Treviño-Palacios C.G., Qureshi N., Mejia-Uriarte E.V. Swept source OCT beyond the coherence length limit. IEEE J. Sel. Top. Quantum Electron. 2016;22:222–227. doi: 10.1109/JSTQE.2016.2556226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/JSTQE.2016.2556226</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S.H., Sin T.N., Dang B., Ngo T., Lo T., Lent-Schochet D., Meleppat R.K., Zawadzki R.J., Yiu G. CRISPR-based VEGF suppression using paired guide RNAs for treatment of choroidal neovascularization. Mol. Ther. Nucleic Acids. 2022;28:613–622. doi: 10.1016/j.omtn.2022.04.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2022.04.015</ArticleId><ArticleId IdType="pmc">PMC9114159</ArticleId><ArticleId IdType="pubmed">35614998</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher N.D., Syed Z.A. Bilateral interstitial keratitis following COVID-19: A case report. BMC Ophthalmol. 2023;23:414. doi: 10.1186/s12886-023-03160-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12886-023-03160-4</ArticleId><ArticleId IdType="pmc">PMC10571384</ArticleId><ArticleId IdType="pubmed">37833623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pareja-Ríos A., Bonaque-González S. Late corneal stromal deposits after covid-19. Cornea. 2021;40:1067–1069. doi: 10.1097/ICO.0000000000002757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICO.0000000000002757</ArticleId><ArticleId IdType="pmc">PMC8244804</ArticleId><ArticleId IdType="pubmed">34029243</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema M., Aghazadeh H., Nazarali S., Ting A., Hodges J., McFarlane A., Kanji J.N., Zelyas N., Damji K.F., Solarte C. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19) Can. J. Ophthalmol. 2020;55:e125–e129. doi: 10.1016/j.jcjo.2020.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2020.03.003</ArticleId><ArticleId IdType="pmc">PMC7124283</ArticleId><ArticleId IdType="pubmed">32284146</ArticleId></ArticleIdList></Reference><Reference><Citation>Méndez Mangana C., Barraquer Kargacin A., Barraquer R.I. Episcleritis as an ocular manifestation in a patient with COVID-19. Acta Ophthalmol. 2020;98:e1056–e1057. doi: 10.1111/aos.14484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.14484</ArticleId><ArticleId IdType="pmc">PMC7300696</ArticleId><ArticleId IdType="pubmed">32483943</ArticleId></ArticleIdList></Reference><Reference><Citation>Oren B., Kocabas D.O. Assessment of corneal endothelial cell morphology and anterior segment parameters in COVID-19. Ther. Adv. Ophthalmol. 2022;14:25158414221096057. doi: 10.1177/25158414221096057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/25158414221096057</ArticleId><ArticleId IdType="pmc">PMC9092573</ArticleId><ArticleId IdType="pubmed">35574183</ArticleId></ArticleIdList></Reference><Reference><Citation>Qazi Y., Wong G., Monson B., Stringham J., Ambati B.K. Corneal transparency: Genesis, maintenance and dysfunction. Brain Res. Bull. 2010;81:198–210. doi: 10.1016/j.brainresbull.2009.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2009.05.019</ArticleId><ArticleId IdType="pmc">PMC3077112</ArticleId><ArticleId IdType="pubmed">19481138</ArticleId></ArticleIdList></Reference><Reference><Citation>Erdem S., Karahan M., Ava S., Dursun M.E., Hazar L., Keklikci U. Examination of the effects of COVID 19 on corneal endothelium. Graefe’s Arch. Clin. Exp. Ophthalmol. 2021;259:2295–2300. doi: 10.1007/s00417-021-05259-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-021-05259-0</ArticleId><ArticleId IdType="pmc">PMC8181541</ArticleId><ArticleId IdType="pubmed">34097111</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail Y.M., Aal M.A., Attia W.H., Hassanin A. Evaluation of corneal structural changes in post-COVID-19 patients using anterior segment optical coherence tomography and specular microscopy. J. Egypt. Ophthalmol. Soc. 2023;116:234–240. doi: 10.4103/ejos.ejos_48_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ejos.ejos_48_23</ArticleId></ArticleIdList></Reference><Reference><Citation>Szkodny D., Wylęgała A., Chlasta-Twardzik E., Wylęgała E. The Ocular Surface Symptoms and Tear Film Parameters during and after COVID-19 Infection. J. Clin. Med. 2022;11:6697. doi: 10.3390/jcm11226697.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11226697</ArticleId><ArticleId IdType="pmc">PMC9695362</ArticleId><ArticleId IdType="pubmed">36431174</ArticleId></ArticleIdList></Reference><Reference><Citation>Colakoglu A., Cosar C.B. Age-Related Changes in Corneal Epithelial Thickness Measured with an Ultrasound Pachymeter. Clin. Interv. Aging. 2022;17:1461–1470. doi: 10.2147/CIA.S378050.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CIA.S378050</ArticleId><ArticleId IdType="pmc">PMC9527701</ArticleId><ArticleId IdType="pubmed">36199975</ArticleId></ArticleIdList></Reference><Reference><Citation>Örnek K., Temel E., Kocamış Ö., Aşıkgarip N., Hızmalı L. Anterior segment parameters in patients with coronavirus disease. Arq. Bras. Oftalmol. 2021;84:301–302. doi: 10.5935/0004-2749.20210087.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/0004-2749.20210087</ArticleId><ArticleId IdType="pubmed">34037127</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinho P.M., Marcos A.A.A., Romano A.C., Nascimento H., Belfort R. Retinal findings in patients with COVID-19. Lancet. 2020;395:1610. doi: 10.1016/S0140-6736(20)31014-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31014-X</ArticleId><ArticleId IdType="pmc">PMC7217650</ArticleId><ArticleId IdType="pubmed">32405105</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira L.A., Soares L.C.M., Nascimento P.A., Cirillo L.R.N., Sakuma H.T., da Veiga G.L., Fonseca F.L.A., Lima V.L., Abucham-Neto J.Z. Retinal findings in hospitalised patients with severe COVID-19. Br. J. Ophthalmol. 2022;106:102–105. doi: 10.1136/bjophthalmol-2020-317576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-317576</ArticleId><ArticleId IdType="pubmed">33067361</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal R., Markan A., Gautam N., Guru R.R., Lakshmi P.V.M., Katoch D., Agarwal A., Singh M.P., Suri V., Mohindra R., et al. Retinal Involvement in COVID-19: Results From a Prospective Retina Screening Program in the Acute and Convalescent Phase. Front. Med. 2021;8:681942. doi: 10.3389/fmed.2021.681942.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.681942</ArticleId><ArticleId IdType="pmc">PMC8264127</ArticleId><ArticleId IdType="pubmed">34249972</ArticleId></ArticleIdList></Reference><Reference><Citation>Lani-Louzada R., do Val Ferreira Ramos C., Cordeiro R.M., Sadun A.A. Retinal changes in COVID-19 hospitalized cases. PLoS ONE. 2020;15:e0243346. doi: 10.1371/journal.pone.0243346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243346</ArticleId><ArticleId IdType="pmc">PMC7714146</ArticleId><ArticleId IdType="pubmed">33270751</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavvas D.G., Sarraf D., Sadda S.R., Eliott D., Ehlers J.P., Waheed N.K., Morizane Y., Sakamoto T., Tsilimbaris M., Miller J.B. Concerns about the interpretation of OCT and fundus findings in COVID-19 patients in recent Lancet publication. Eye. 2020;34:2153–2154. doi: 10.1038/s41433-020-1084-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-020-1084-9</ArticleId><ArticleId IdType="pmc">PMC7347265</ArticleId><ArticleId IdType="pubmed">32647303</ArticleId></ArticleIdList></Reference><Reference><Citation>Szkodny D., Wylęgała E., Sujka-Franczak P., Chlasta-Twardzik E., Fiolka R., Tomczyk T., Wylęgała A. Retinal oct findings in patients after covid infection. J. Clin. Med. 2021;10:3233. doi: 10.3390/jcm10153233.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10153233</ArticleId><ArticleId IdType="pmc">PMC8347407</ArticleId><ArticleId IdType="pubmed">34362017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kal M., Brzdęk M., Zarębska-Michaluk D., Pinna A., Mackiewicz J., Odrobina D., Winiarczyk M., Karska-Basta I. Optical Coherence Tomography Angiography Assessment of the Optic Nerve Head in Patients Hospitalized Due to COVID-19 Bilateral Pneumonia. Medicina. 2024;60:502. doi: 10.3390/medicina60030502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina60030502</ArticleId><ArticleId IdType="pmc">PMC10972053</ArticleId><ArticleId IdType="pubmed">38541228</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A., Dequanter D., Blecic S., El Afia F., Distinguin L., et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. Eur. Arch. Oto-Rhino-Laryngol. 2020;277:2251–2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgos-Blasco B., Güemes-Villahoz N., Vidal-Villegas B., Martinez-De-La-Casa J.M., Donate-Lopez J., Martín-Sánchez F.J., González-Armengol J.J., Porta-Etessam J., Martin J.L.R., Garcia-Feijoo J. Optic nerve and macular optical coherence tomography in recovered COVID-19 patients. Eur. J. Ophthalmol. 2022;32:628–636. doi: 10.1177/11206721211001019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11206721211001019</ArticleId><ArticleId IdType="pubmed">33719624</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A., Crincoli E., Savastano M.C., Younis S., Gambini G., De Vico U., Cozzupoli G.M., Culiersi C., Rizzo S., Gemelli Against COVID-19 Post-Acute Care Study Group Peripapillary retinal vascular involvement in early post-COVID-19 patients. J. Clin. Med. 2020;9:2895. doi: 10.3390/jcm9092895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092895</ArticleId><ArticleId IdType="pmc">PMC7565672</ArticleId><ArticleId IdType="pubmed">32911619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ullah I., Sohail A., Alam Shah M.U.F., Khurshid M., Diwan M.N., Qadir A., Irfan M. Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review. Ann. Med. Surg. 2021;71:102898. doi: 10.1016/j.amsu.2021.102898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2021.102898</ArticleId><ArticleId IdType="pmc">PMC8500694</ArticleId><ArticleId IdType="pubmed">34659743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bapaye M.M., Nair A.G., Bapaye C.M., Bapaye M.M., Shukla J.J. Simultaneous Bilateral Central Retinal Artery Occlusion following COVID-19 Infection. Ocul. Immunol. Inflamm. 2021;29:671–674. doi: 10.1080/09273948.2021.1891262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2021.1891262</ArticleId><ArticleId IdType="pubmed">33856275</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayram N., Gundogan M., Ozsaygılı C., Adelman R.A. Posterior ocular structural and vascular alterations in severe COVID-19 patients. Graefe’s Arch. Clin. Exp. Ophthalmol. 2022;260:993–1004. doi: 10.1007/s00417-021-05420-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-021-05420-9</ArticleId><ArticleId IdType="pmc">PMC8488325</ArticleId><ArticleId IdType="pubmed">34605953</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrishami M., Daneshvar R., Emamverdian Z., Tohidinezhad F., Eslami S. Optic Nerve Head Parameters and Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Coronavirus Disease 2019. Ocul. Immunol. Inflamm. 2022;30:1035–1038. doi: 10.1080/09273948.2020.1850800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2020.1850800</ArticleId><ArticleId IdType="pubmed">33606593</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrishami M., Hassanpour K., Hosseini S., Shoeibi N., Ansari-Astaneh M.R., Emamverdian Z., Gharib B., Amini N., Abrishami M. Peripapillary Nerve Fiber Layer Thickness and Optic Nerve Head Parameters in Patients Recovered from COVID-19: A Longitudinal Study. J. Ophthalmol. 2022;2022:4643973. doi: 10.1155/2022/4643973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4643973</ArticleId><ArticleId IdType="pmc">PMC8968351</ArticleId><ArticleId IdType="pubmed">35368999</ArticleId></ArticleIdList></Reference><Reference><Citation>Hondur G., Göktaş E., Al-Aswad L., Tezel G. Age-related changes in the peripheral retinal nerve fiber layer thickness. Clin. Ophthalmol. 2018;12:401–409. doi: 10.2147/OPTH.S157429.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OPTH.S157429</ArticleId><ArticleId IdType="pmc">PMC5833791</ArticleId><ArticleId IdType="pubmed">29520130</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar K., Meglič A., Lapajne L., Logar M., Valentinčič N.V., Petrovič M.G., Mekjavić P.J. The impact of acute COVID-19 on the retinal microvasculature assessed with multimodal imaging. Graefe’s Arch. Clin. Exp. Ophthalmol. 2023;261:1115–1125. doi: 10.1007/s00417-022-05887-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-022-05887-0</ArticleId><ArticleId IdType="pmc">PMC9638292</ArticleId><ArticleId IdType="pubmed">36334115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kal M., Winiarczyk M., Cieśla E., Płatkowska-Adamska B., Walczyk A., Biskup M., Pabjan P., Głuszek S., Odrobina D., Mackiewicz J., et al. Retinal Microvascular Changes in COVID-19 Bilateral Pneumonia Based on Optical Coherence Tomography Angiography. J. Clin. Med. 2022;11:3621. doi: 10.3390/jcm11133621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11133621</ArticleId><ArticleId IdType="pmc">PMC9267319</ArticleId><ArticleId IdType="pubmed">35806907</ArticleId></ArticleIdList></Reference><Reference><Citation>Dag Seker E., Erbahceci Timur I.E. COVID-19: More than a respiratory virus, an optical coherence tomography study. Int. Ophthalmol. 2021;41:3815–3824. doi: 10.1007/s10792-021-01952-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-021-01952-5</ArticleId><ArticleId IdType="pmc">PMC8315248</ArticleId><ArticleId IdType="pubmed">34318370</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Team . Oxygen Sources and Distribution for COVID-19 Treatment Centres Interim Guidance 4 April 2020 Background. World Health Organization; Geneva, Switzerland: 2020. p. 1.</Citation></Reference><Reference><Citation>Ceylan I., Korkmaz H.A., Ulutaş H.G. Eye care in intensive care in COVID-19 era: A prospective observational study from Turkey. Eur. Rev. Med. Pharmacol. Sci. 2022;26:2165–2170. doi: 10.26355/eurrev_202203_28364.</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202203_28364</ArticleId><ArticleId IdType="pubmed">35363366</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.P.M., Ko C.-N., Zheng K., Lai K.H.F., Wong R.L.F., Lee A.F., Zhang S., Huang S.S.M., Wan K.H.M., Lam D.S.M. COVID-19: Update on Its Ocular Involvements, and Complications from Its Treatments and Vaccinations. Asia-Pac. J. Ophthalmol. 2021;10:521–529. doi: 10.1097/APO.0000000000000453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/APO.0000000000000453</ArticleId><ArticleId IdType="pmc">PMC8673850</ArticleId><ArticleId IdType="pubmed">34839344</ArticleId></ArticleIdList></Reference><Reference><Citation>The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Shankar-Hari M., Vale C.L., Godolphin P.J., Fisher D., Higgins J.P.T., Spiga F., Savović J., Tierney J., Baron G., et al. Association between Administration of IL-6 Antagonists and Mortality among Patients Hospitalized for COVID-19: A Meta-analysis. JAMA—J. Am. Med. Assoc. 2021;326:499–518. doi: 10.1001/jama.2021.11330.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11330</ArticleId><ArticleId IdType="pmc">PMC8261689</ArticleId><ArticleId IdType="pubmed">34228774</ArticleId></ArticleIdList></Reference><Reference><Citation>Abidi E., El Nekidy W.S., Alefishat E., Rahman N., Petroianu G.A., El-Lababidi R., Mallat J. Tocilizumab and COVID-19: Timing of Administration and Efficacy. Front. Pharmacol. 2022;13:825749. doi: 10.3389/fphar.2022.825749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.825749</ArticleId><ArticleId IdType="pmc">PMC8894855</ArticleId><ArticleId IdType="pubmed">35250575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q., Lin H., Wei R.-G., Chen N., He F., Zou D.-H., Wei J.-R. Tocilizumab treatment for COVID-19 patients: A systematic review and meta-analysis. Infect. Dis. Poverty. 2021;10:71. doi: 10.1186/s40249-021-00857-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-021-00857-w</ArticleId><ArticleId IdType="pmc">PMC8128625</ArticleId><ArticleId IdType="pubmed">34001244</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorda A., Kussmann M., Kolenchery N., Siller-Matula J.M., Zeitlinger M., Jilma B., Gelbenegger G. Convalescent Plasma Treatment in Patients with COVID-19: A Systematic Review and Meta-Analysis. Front. Immunol. 2022;13:817829. doi: 10.3389/fimmu.2022.817829.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.817829</ArticleId><ArticleId IdType="pmc">PMC8859444</ArticleId><ArticleId IdType="pubmed">35197981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zein M., Wylegala A.M., Sripawadkul W., Al Bayyat G., Alvarez O.P.B., Gutierrez A.J.N., Guerrero M.A.C., Galor A.M., Karp C.L. Corneal topography and tomography readings with mask wear during the COVID-19 pandemic. J. Cataract Refract. Surg. 2023;49:285–291. doi: 10.1097/j.jcrs.0000000000001090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.jcrs.0000000000001090</ArticleId><ArticleId IdType="pmc">PMC10043756</ArticleId><ArticleId IdType="pubmed">36399667</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>